250 results on '"Chegaev, Konstantin"'
Search Results
2. In vitro vascular toxicity assessment of NitDOX, a novel NO-releasing doxorubicin
3. Special Issue "Development and Synthesis of Biologically Active Compounds".
4. Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation
5. Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors
6. Structural and biological characterization of new hybrid drugs joining an HDAC inhibitor to different NO-donors
7. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma
8. New NO- and H2S-releasing doxorubicins as targeted therapy against chemoresistance in castration-resistant prostate cancer: in vitro and in vivo evaluations
9. Contributors
10. In Vitro Assessment of NitDox Toxicity Toward Vasculature
11. Synthesis and biological activity of furoxan derivatives against Mycobacterium tuberculosis
12. New lipophilic organic nitrates: candidates for chronic skin disease therapy
13. Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage
14. Overcoming multidrug resistance by targeting mitochondria with NO-donating doxorubicins
15. NO-donor thiacarbocyanines as multifunctional agents for Alzheimer’s disease
16. N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation
17. Naked and Decorated Nanoparticles Containing H2S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells
18. Furazan and furoxan sulfonamides are strong α-carbonic anhydrase inhibitors and potential antiglaucoma agents
19. Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells.
20. A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors
21. Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage.
22. Synthesis physicochemical profile and PAMPA study of new NO-donor edaravone co-drugs
23. A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors
24. Multitarget antioxidant NO-donor organic nitrates: a novel approach to overcome nitrates tolerance
25. Direct introduction of cyano group on furoxan ring
26. Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo Study
27. Naked and Decorated Nanoparticles Containing H 2 S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells.
28. Novel antioxidant agents deriving from molecular combination of Vitamin C and NO-donor moieties
29. MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells
30. A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors.
31. NO release regulated by doxorubicin as the green light-harvesting antenna
32. NO-donor melatonin derivatives: synthesis and in vitro pharmacological characterization
33. Paracetamol–Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug
34. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts
35. Correction to “Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance”
36. Endoplasmic reticulum-targeting doxorubicin: a new tool effective against doxorubicin-resistant osteosarcoma
37. New furoxan derivatives for the treatment of ocular hypertension
38. Aceclofenac–Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations
39. New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro
40. Mitochondrial Delivery of Phenol Substructure Triggers Mitochondrial Depolarization and Apoptosis of Cancer Cells
41. New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme
42. New tetrahydroisoquinoline-based P-glycoprotein modulators: decoration of the biphenyl core gives selective ligands
43. Galactosylated Pro–Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis
44. MODIFIED DOXORUBICINS: 'GASEOUS APPROACH' TO OVERCOME CARDIOTOXICITY AND MULTIDRUG RESISTANCE
45. Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity
46. gem-Dinitroalkyl Benzenes: A Novel Class of IOP-Lowering Agents for the Treatment of Ocular Hypertension
47. Solid Lipid Nanoparticles Loaded with Antitumor Lipophilic Prodrugs Aimed to Glioblastoma Treatment: Preliminary Studies on Cultured Cells
48. Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance
49. Screening for potential hazard effects from a multitarget anthracycline on the cardiovascular system
50. Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.